1. Home
  2. HNI vs LGND Comparison

HNI vs LGND Comparison

Compare HNI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • LGND
  • Stock Information
  • Founded
  • HNI 1944
  • LGND 1987
  • Country
  • HNI United States
  • LGND United States
  • Employees
  • HNI N/A
  • LGND 68
  • Industry
  • HNI Office Equipment/Supplies/Services
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • LGND Health Care
  • Exchange
  • HNI Nasdaq
  • LGND Nasdaq
  • Market Cap
  • HNI 2.4B
  • LGND 2.2B
  • IPO Year
  • HNI N/A
  • LGND 1992
  • Fundamental
  • Price
  • HNI $43.20
  • LGND $146.14
  • Analyst Decision
  • HNI Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • HNI 2
  • LGND 8
  • Target Price
  • HNI $66.50
  • LGND $144.71
  • AVG Volume (30 Days)
  • HNI 565.3K
  • LGND 139.7K
  • Earning Date
  • HNI 07-24-2025
  • LGND 08-05-2025
  • Dividend Yield
  • HNI 3.12%
  • LGND N/A
  • EPS Growth
  • HNI 30.07
  • LGND N/A
  • EPS
  • HNI 3.08
  • LGND N/A
  • Revenue
  • HNI $2,581,500,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • HNI $5.72
  • LGND $18.41
  • Revenue Next Year
  • HNI $3.63
  • LGND $18.87
  • P/E Ratio
  • HNI $14.15
  • LGND N/A
  • Revenue Growth
  • HNI N/A
  • LGND 53.40
  • 52 Week Low
  • HNI $39.76
  • LGND $81.74
  • 52 Week High
  • HNI $58.42
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • HNI 23.78
  • LGND 68.73
  • Support Level
  • HNI $40.05
  • LGND $132.21
  • Resistance Level
  • HNI $51.58
  • LGND $149.21
  • Average True Range (ATR)
  • HNI 1.85
  • LGND 5.37
  • MACD
  • HNI -1.13
  • LGND 0.53
  • Stochastic Oscillator
  • HNI 22.73
  • LGND 83.70

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: